GO:0090071 negative regulation of ribosome biogenesis: Protein Synthesis Control, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0090071 describes any process that decreases the rate, frequency or extent of ribosome biogenesis, the cellular process that builds ribosomal subunits.
• Negative regulation of ribosome biogenesis is an active, signal-driven checkpoint that couples cell growth, proliferation and stress responses to ribosome output.
• The Arf tumor suppressor is a classic example of a factor that restrains ribosome biogenesis to control cell proliferation.
• Small non-coding RNAs, including microRNAs and small nucleolar RNAs, can act as repressors of ribosome biogenesis.
• Signaling kinases such as GSK-3 and metabolic stress pathways modulate ribosome biogenesis in skeletal muscle under disuse conditions.
• Dysregulation of this process is linked to cancer, senescence, ribosomopathies and muscle wasting, making it a rich target for CRISPR-based functional studies.
Description
Ribosome biogenesis is one of the most energy-consuming activities of a growing cell, and its rate must be tightly matched to nutrient availability, stress and proliferative signals. GO:0090071, negative regulation of ribosome biogenesis, captures the biological processes that actively decrease the rate, frequency or extent of this biosynthetic program. Rather than a passive shutdown, this term describes regulated checkpoints that prevent excessive ribosome production and coordinate it with cell fate decisions. Understanding GO:0090071 matters because ribosome output is a central determinant of cell growth, and its misregulation is increasingly implicated in cancer, senescence and tissue-wasting conditions. Experimental work has shown that tumor suppressors such as Arf can restrain ribosome biogenesis as part of an anti-proliferative program. More recently, non-coding RNAs have emerged as repressors of ribosome biogenesis, expanding the repertoire of factors that fall under this GO term. In parallel, signaling kinases such as GSK-3 have been shown to regulate ribosome biogenesis in skeletal muscle under disuse conditions, linking this process to muscle physiology. This article integrates the QuickGO definition with verified PubMed literature to provide a research-grade overview of GO:0090071, its mechanisms, key genes and the CRISPR-based methods used to study it.
negative regulation of ribosome biogenesis At A Glance
| GO ID | GO:0090071 |
|---|---|
| GO term | negative regulation of ribosome biogenesis |
| Ontology | biological_process |
| Synonym | none listed in QuickGO |
| Major function | Decreases the rate, frequency or extent of ribosome biogenesis |
| Biological context | Cell growth, proliferation, stress response and senescence |
| Representative regulators | Arf, microRNAs, small nucleolar RNAs, GSK-3 |
| Disease relevance | Cancer, senescence, ribosomopathies and muscle wasting |
What Is GO:0090071?
GO:0090071, negative regulation of ribosome biogenesis, is a biological process term defined as any process that decreases the rate, frequency or extent of ribosome biogenesis. Ribosome biogenesis itself is the cellular process that results in the biosynthesis of constituent macromolecules, assembly, and arrangement of constituent parts of ribosome subunits. In practice, this term covers signaling events, RNA-binding proteins, non-coding RNAs and checkpoint pathways that actively suppress the production of new ribosomes.
Why Is negative regulation of ribosome biogenesis Important in Cell Biology?
Negative regulation of ribosome biogenesis is important because ribosome production is a major biosynthetic commitment that must be suppressed when cells face stress, differentiation cues or anti-proliferative signals. Loss of this control can lead to excessive ribosome output, which is a hallmark of many cancers and a driver of aberrant growth. Conversely, excessive repression contributes to senescence and to tissue-wasting conditions such as muscle disuse atrophy. Because this process sits at the intersection of signaling, RNA biology and metabolism, it is a fertile area for functional genomics and CRISPR screening.
• Controls cell proliferation by restraining ribosome output.
• Acts as a tumor-suppressive checkpoint through factors such as Arf.
• Is modulated by non-coding RNAs including microRNAs and small nucleolar RNAs.
• Links nutrient and stress signaling to ribosome production.
• Contributes to senescence programs when ribosome biogenesis is suppressed.
• Is regulated in skeletal muscle under disuse conditions via GSK-3.
• Provides a mechanistic explanation for ribosomopathy phenotypes.
• Offers targets for anti-cancer and anti-aging interventions.
• Is amenable to CRISPR knockout, knock-in and overexpression modeling.
• Supports biomarker discovery through Ribo-seq and proteomics.
What Happens During negative regulation of ribosome biogenesis?
Initiation of repression signals
In simple terms: The cell receives a signal that says 'stop making so many ribosomes'.
Negative regulation of ribosome biogenesis begins when anti-proliferative or stress signals activate repressor pathways. The Arf tumor suppressor is a classic example of a factor that initiates such a repressive program to control cell proliferation. These signals converge on the transcriptional and post-transcriptional machinery that governs ribosomal RNA and ribosomal protein production.
Non-coding RNA-mediated repression
In simple terms: Small RNA molecules can act as brakes on ribosome production.
MicroRNAs and small nucleolar RNAs have been identified as repressors of ribosome biogenesis. A non-canonical role for a small nucleolar RNA in ribosome biogenesis and senescence has been demonstrated, showing that these RNAs can directly modulate ribosome output. Discovery screens have uncovered novel microRNA mimic repressors of ribosome biogenesis, expanding the list of non-coding regulators.
Kinase and metabolic control
In simple terms: Enzymes that sense the cell's energy and stress state can dial down ribosome building.
Glycogen synthase kinase-3 (GSK-3) plays a role in regulating ribosome biogenesis in rat soleus muscle under disuse conditions. This illustrates how metabolic and signaling kinases can suppress ribosome biogenesis in response to physiological challenges. Such kinase-dependent control provides a reversible mechanism for tuning ribosome output.
Downstream consequences for growth and senescence
In simple terms: When ribosome production is slowed, cells may stop dividing or enter a dormant state.
Suppression of ribosome biogenesis is linked to reduced proliferation and to the induction of senescence. The Arf-dependent pathway is proposed as a mechanism by which negative regulation of ribosome biogenesis controls cell proliferation. In skeletal muscle, disuse conditions trigger GSK-3-dependent changes in ribosome biogenesis that contribute to muscle remodeling.
Key Genes Involved in GO:0090071 negative regulation of ribosome biogenesis
The following genes and non-coding regulators have been experimentally linked to negative regulation of ribosome biogenesis or to its regulatory network.
| Gene | Major Role | Research Relevance |
|---|---|---|
| CDKN2A (Arf) | Tumor suppressor that restrains ribosome biogenesis | Classic model for Arf-dependent proliferation control |
| GSK3A/GSK3B | Kinases regulating ribosome biogenesis in muscle | Studied in disuse-induced muscle remodeling |
| miR-1 | MicroRNA repressor of ribosome biogenesis | Identified in mimic repressor screens |
| miR-133 | MicroRNA repressor of ribosome biogenesis | Identified in mimic repressor screens |
| snoRNA | Small nucleolar RNA with non-canonical repressive role | Linked to senescence and ribosome biogenesis |
| MYC | Oncogene driving ribosome biogenesis | Context for negative regulation studies |
| mTOR | Kinase integrating growth signals to ribosome biogenesis | Upstream regulator of the process |
| TP53 | Tumor suppressor coordinating stress responses | Interacts with Arf-dependent repression |
| RPL5 | Ribosomal protein component | Ribosomopathy-related gene |
| RPL11 | Ribosomal protein component | Ribosomopathy-related gene |
| RPS19 | Ribosomal protein component | Diamond-Blackfan anemia gene |
| SBDS | Ribosome assembly factor | Shwachman-Diamond syndrome gene |
| DKC1 | Ribosome biogenesis factor | Dyskeratosis congenita gene |
| NPM1 | Nucleolar protein involved in ribosome assembly | Studied in ribosome biogenesis regulation |
| UTP14A | Small subunit processome component | Ribosome biogenesis factor |
| PES1 | Pre-rRNA processing factor | Ribosome biogenesis factor |
| BOP1 | Pre-rRNA processing factor | Ribosome biogenesis factor |
How Is negative regulation of ribosome biogenesis Regulated?
Negative regulation of ribosome biogenesis is controlled by multiple layers of regulation. The Arf tumor suppressor provides an anti-proliferative signal that restrains ribosome production. Non-coding RNAs, including microRNAs and small nucleolar RNAs, add post-transcriptional repression. In skeletal muscle, GSK-3 activity modulates ribosome biogenesis under disuse conditions, linking physiological state to ribosome output. These regulatory inputs ensure that ribosome production is matched to the cell's growth and stress status.
negative regulation of ribosome biogenesis and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| CDKN2A (Arf) | Cancer, proliferation control | Arf knockout and overexpression cell lines |
| GSK3A/GSK3B | Muscle disuse atrophy | Rat soleus disuse model with GSK-3 manipulation |
| snoRNA | Senescence | snoRNA knockout and overexpression models |
| RPS19 | Diamond-Blackfan anemia | RPS19 mutant knock-in models |
| SBDS | Shwachman-Diamond syndrome | SBDS knockout and point-mutation models |
Cancer and uncontrolled proliferation
Loss of negative regulation of ribosome biogenesis can contribute to excessive ribosome production and uncontrolled cell proliferation. The Arf-dependent pathway is proposed as a tumor-suppressive mechanism that restrains ribosome biogenesis. Restoring repressive control is therefore an attractive anti-cancer strategy.
Senescence and aging
A non-canonical role for a small nucleolar RNA in ribosome biogenesis and senescence has been demonstrated, linking repression of ribosome biogenesis to cellular aging. Probiotic supplementation has been shown to attenuate age-related sarcopenia via the gut-muscle axis in SAMP8 mice, a model in which muscle ribosome biogenesis is relevant. These findings connect ribosome biogenesis regulation to age-related tissue decline.
Ribosomopathies
Mutations in ribosomal protein genes and assembly factors cause ribosomopathies such as Diamond-Blackfan anemia and Shwachman-Diamond syndrome. Negative regulation of ribosome biogenesis is central to understanding how reduced ribosome output produces tissue-specific defects. Studying this GO term helps explain the genotype-phenotype relationships in these disorders.
Muscle wasting and disuse atrophy
GSK-3-dependent regulation of ribosome biogenesis in rat soleus muscle under disuse conditions links this process to muscle atrophy. Skeletal muscle hypertrophy requires coordinated ribosome biogenesis, and its negative regulation is part of the remodeling response. Interventions that modulate this process may help preserve muscle mass.
From negative regulation of ribosome biogenesis-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of a candidate repressor increase ribosome biogenesis? | CRISPR knockout cell line |
| Does a specific point mutation abolish repressor function? | Point-mutation knock-in |
| Can a tagged repressor be tracked in live cells? | Tagged knock-in |
| Does overexpression of a microRNA mimic reduce ribosome biogenesis? | Overexpression cell model |
| Which genes modify the repression phenotype? | CRISPR library screening |
| How does GSK-3 inhibition affect ribosome biogenesis in muscle? | In vivo disuse model with pharmacological or genetic manipulation |
How to Study the negative regulation of ribosome biogenesis Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Ribo-seq | Ribosome footprint density | Quantifying translation and ribosome output |
| Polysome profiling | Distribution of mRNAs across polysomes | Assessing ribosome biogenesis changes |
| RNA-seq | Transcript abundance | Identifying repressor-regulated genes |
| Small RNA sequencing | MicroRNA and snoRNA expression | Discovering non-coding repressors |
| Proteomics | Protein abundance and modifications | Quantifying ribosomal proteins |
| Nucleolar imaging | Nucleolar size and number | Validating repression phenotypes |
| CRISPR screening | Gene essentiality and modifier effects | Finding novel regulators |
| Immunoblotting | Protein levels of repressors | Confirming knockout or overexpression |
Ribo-seq and polysome profiling
Ribo-seq and polysome profiling measure the translational output of cells and can reveal changes in ribosome biogenesis when negative regulators are manipulated. These methods are used to quantify how repressors such as microRNAs or snoRNAs alter ribosome production.
RNA-seq and small RNA sequencing
RNA-seq and small RNA sequencing identify transcriptional and non-coding RNA changes associated with negative regulation of ribosome biogenesis. They are used in discovery screens for microRNA mimic repressors.
Proteomics and interactomics
Proteomic approaches can quantify ribosomal proteins and assembly factors, providing a direct readout of ribosome biogenesis. Interactomics can identify protein partners of repressors such as Arf.
Imaging of nucleolar structure
Fluorescence imaging of nucleolar markers can reveal changes in nucleolar size and number, which correlate with ribosome biogenesis activity. This is useful for validating repressor function in live cells.
How CRISPR Can Be Used to Study GO:0090071 negative regulation of ribosome biogenesis
Knockout
CRISPR knockout of candidate repressors such as CDKN2A (Arf) can test whether loss of function increases ribosome biogenesis and proliferation. Knockout of GSK3A/GSK3B in muscle models can reveal their role in disuse-induced changes. Knockout of snoRNA loci can test non-canonical repressive functions.
Point Mutation
Point-mutation knock-in can dissect which residues of a repressor are required for its function. For example, mutations in ribosomal protein genes can model ribosomopathy-associated lesions. Point mutations in kinase domains of GSK-3 can separate catalytic from scaffolding functions.
Knock-in
Tagged knock-in of repressors allows live-cell tracking of their localization and dynamics. Knock-in of reporter cassettes under the control of ribosome biogenesis genes can provide sensitive readouts. Knock-in of disease-associated mutations can model ribosomopathies.
Overexpression
Overexpression of microRNA mimics or repressor proteins can suppress ribosome biogenesis and induce senescence or growth arrest. Overexpression models are useful for testing sufficiency of a candidate repressor. They also enable dose-response studies of ribosome biogenesis inhibition.
How EDITGENE Supports negative regulation of ribosome biogenesis Research
Researchers studying negative regulation of ribosome biogenesis-related genes often need to determine whether a candidate gene is causally involved in repressing ribosome output, and CRISPR-based models provide the most direct way to test this. EDITGENE offers a full suite of services to generate and characterize such models.
Contact EDITGENE today to design your custom CRISPR model for negative regulation of ribosome biogenesis research.
Frequently Asked Questions About negative regulation of ribosome biogenesis
What is GO:0090071?
GO:0090071 is the Gene Ontology term for negative regulation of ribosome biogenesis, defined as any process that decreases the rate, frequency or extent of ribosome biogenesis.
What is negative regulation of ribosome biogenesis?
It is the active suppression of the cellular process that builds ribosomal subunits, often in response to stress or anti-proliferative signals.
What genes are involved in negative regulation of ribosome biogenesis?
Key genes include CDKN2A (Arf), GSK3A/GSK3B, and non-coding RNAs such as microRNAs and small nucleolar RNAs.
How is ribosome biogenesis negatively regulated?
It is regulated by tumor suppressors like Arf, by non-coding RNAs, and by signaling kinases such as GSK-3.
Why is negative regulation of ribosome biogenesis important in cancer?
Loss of this repression can lead to excessive ribosome production and uncontrolled proliferation, making it a tumor-suppressive mechanism.
What is the role of Arf in ribosome biogenesis?
Arf is a tumor suppressor that initiates an anti-proliferative pathway that restrains ribosome biogenesis.
How do microRNAs repress ribosome biogenesis?
MicroRNA mimics have been discovered that act as repressors of ribosome biogenesis, though the precise mechanisms vary.
What methods study negative regulation of ribosome biogenesis?
Ribo-seq, polysome profiling, RNA-seq, proteomics, imaging and CRISPR screening are commonly used.
Is negative regulation of ribosome biogenesis linked to aging?
Yes, a small nucleolar RNA has been linked to ribosome biogenesis and senescence, and muscle disuse models show regulation by GSK-3.
How can CRISPR help study GO:0090071?
CRISPR knockout, knock-in, point mutation and overexpression models allow causal testing of candidate repressors.
Conclusion
GO:0090071, negative regulation of ribosome biogenesis, is a critical biological process that restrains one of the cell's most expensive biosynthetic activities. Its regulation by tumor suppressors, non-coding RNAs and kinases connects it to cancer, senescence, ribosomopathies and muscle wasting. CRISPR-based models offer a powerful way to dissect the causal roles of individual regulators and to discover new therapeutic targets.
References
- 1. Schiaffino S et al.. 2021. Molecular Mechanisms of Skeletal Muscle Hypertrophy.. J Neuromuscul Dis 8(2):169-183 PMID: 33216041
- 2. Cheng Y et al.. 2024. A non-canonical role for a small nucleolar RNA in ribosome biogenesis and senescence.. Cell 187(17):4770-4789.e23 PMID: 38981482
- 3. Chen LH et al.. 2022. Probiotic supplementation attenuates age-related sarcopenia via the gut-muscle axis in SAMP8 mice.. J Cachexia Sarcopenia Muscle 13(1):515-531 PMID: 34766473
- 4. Ayrault O et al.. 2006. [The negative regulation of ribosome biogenesis: a new Arf-dependent pathway controlling cell proliferation?].. Med Sci (Paris) 22(5):519-24 PMID: 16687121
- 6. Bryant CJ et al.. 2024. Discovery of novel microRNA mimic repressors of ribosome biogenesis.. Nucleic Acids Res 52(4):1988-2011 PMID: 38197221
- 7. Bryant CJ et al.. 2023. Discovery of novel microRNA mimic repressors of ribosome biogenesis.. bioRxiv PMID: 36824951
- 8. Rozhkov SV et al.. 2022. The Role of Glycogen Synthase Kinase-3 in the Regulation of Ribosome Biogenesis in Rat Soleus Muscle under Disuse Conditions.. Int J Mol Sci 23(5) PMID: 35269893
